CSI Market
Sign In | Register

Lava Therapeutics Nv (LVTX) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access LVTX quarterly Cash Flow →
The data below summarizes Lava Therapeutics Nv's cash flow activity from to Dec 31 2024, enabling a period-by-period view of cash movement.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2024)
12 Months 		(Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Operating Activities
Income-25.11
Depreciation & amortization0.50
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Asset Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation3.23
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction1.97
Adjustments For Depreciation And Amortisation Expense-
Adjustments For Income Tax Expense-
Adjustment For Amortization Of Premium On Investments-
Adjustments For Decrease Increase In Trade And Other Receivables-
Adjustments For Increase Decrease In Value Added Tax Receivable-
Adjustments For Increase Decrease In Trade And Other Payables-
Adjustments For Increase Decrease In Deferred Offering Costs-
Adjustments For Increase Decrease In Contract Liabilities-
Adjustments For Increase Decrease In Research And Development License Liabilities-
Non Cash Operating Lease Expense0.37
Adjustment Foreign Currency Gain Loss0.75
Accrued Interest Income Expenses On Borrowings0.52
Increase Decrease In Operating Lease Liability-0.40
Increase Decrease In License Liabilities-
Income taxes-0.01
Proceeds From Disposal Or Maturity Of Availableforsale Financial Assets0.00
Accounts Receivable0.00
Increase (Decrease) in Accounts Payable-1.57
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities5.70
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.42
Other Working Capital-0.23
Other Noncash Income (Expense)0.00
Other net2.64
Payments for (Proceeds from) Other Operating Activities-4.13
Discontinued operations0.00
Net Cash flow from Operating Activities-19.54
Investing Activities
Capital Expenditures0.02
Sale of Capital Items0.09
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Proceeds From Sales Of Investments Other Than Investments Accounted For Using Equity Method-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Proceeds from Sale, Maturity and Collection of Investments97.09
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities12.48
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings-0.60
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.03
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Issue Of Ordinary Shares-
Proceeds From Issue Of Preference Shares-
Payments To Acquire Or Redeem Entitys Shares-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-0.57
Effect of exchange rate on cash flow-1.58
Discontinued operations0.00
Free Cash Flow-19.43
Total Cash Flow-7.64
4 historic quarters locked

Sign in to unlock the full Lava Therapeutics Nv cash flow history.

Sign In Create Free Account

About Lava Therapeutics Nv Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001558370-25-003988

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License